Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Perspectives
Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,038 | Dovepress* | 6,675+ | 184 | 6,859 | |
| PubMed Central* | 2,363 | 433 | 2,796 | ||
| Totals | 9,038 | 617 | 9,655 | ||
| *Since 24 August 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 44 | 0 | 0 | 0 | 5 | 39 |
View citations on PubMed Central and Google Scholar